November 24, 1998 Mr. Tom Wudarski Office of Research Affairs 1020 Locust Street JAH Room M-5 Philadelphia, Pa. 19107 Dear Tom: By this letter, I would like to formally propose the extension of funding under the Clinical Study and Research Agreement...Clinical Study and Research Agreement • March 31st, 1999 • Avax Technologies Inc • Biological products, (no disgnostic substances)
SERIES C CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENTSeries C Convertible Preferred Stock and Warrant Purchase Agreement • March 31st, 1999 • Avax Technologies Inc • Biological products, (no disgnostic substances) • Delaware
